The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
Open accessAbstract
Nearly two decades have passed since it was first proposed that regulation of the interconvertible sphingolipid metabolites, ceramide and sphingosine-1-phosphate (S1P), and their opposing signaling pathways are major determinants of cell fate, a concept referred to as the “sphingolipid rheostat”. Since then, many reports have substantiated the role of the sphingolipid rheostat in cell fate determination and in the initiation, progression, and drug sensitivity of cancer. Thus, modulation of the rheostat has emerged as a focus for treatment strategies to battle cancer. S1P regulates numerous processes important for cancer including proliferation, transformation, angiogenesis, metastasis, survival, and drug resistance. Ceramide on the other hand has been linked to cell growth arrest and cell death. With the increased understanding of sphingolipid metabolism and signaling, as well as the present focus on therapies designed to modulate the levels of sphingolipids in cancer, it is an appropriate time to re-examine the sphingolipid rheostat concept and determine how it fits within the current knowledge of sphingolipid signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S., & Spiegel, S. (1996) · Nature · doi:10.1038/381800a0 · Cited by 1,529
Self-citationCeramide-orchestrated signalling in cancer cells
Morad, S. A. F., & Cabot, M. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3398 · Cited by 1,014
Sphingosine-1-Phosphate as a Ligand for the G Protein-Coupled Receptor EDG-1
Lee, M.-J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., & Hla, T. (1998) · Science · doi:10.1126/science.279.5356.1552 · Cited by 1,007
Self-citationRegulation of histone acetylation in the nucleus by sphingosine-1-phosphate
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., et al. (2009) · Science · doi:10.1126/science.1176709 · Cited by 997
Self-citationSphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
Olivera, A., & Spiegel, S. (1993) · Nature · doi:10.1038/365557a0 · Cited by 889
Self-citationSphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T., et al. (2010) · Nature · doi:10.1038/nature09128 · Cited by 752
Self-citation
Cited by
Pyne, N. J., Adams, D. R., & Pyne, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.003 · Cited by 43
Proton-driven alternating access in a spinster lipid transporter
(2022) · doi:10.1038/s41467-022-32759-2 · Cited by 30
Metadata
- Authors
- Newton, J., Lima, S., Maceyka, M., & Spiegel, S.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 333
- Issue
- 2
- Pages
- 195-200
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W1994625058
- Cited by
- 282
- References
- 42
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. https://app.cochat.ai/papers/10.1016/j.yexcr.2015.02.025
- The paper
- Newton, J., Lima, S., Maceyka, M., & Spiegel, S. (2015). Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. Experimental Cell Research. https://doi.org/10.1016/j.yexcr.2015.02.025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.